News has gone from bad to worse for U.K-based vaccine maker, AstraZeneca. After a prolonged pause across the European Union, the shot has been officially withdrawn due to its strong association with serious blood clots. A final blow came recently as the EU Commission decided to terminate both AstraZeneca and Johnson & Johnson's contracts at their expiry.